SCHEMBL7087375

SCHEMBL7087375

C=C(CN1CCNCC1)CN(Cc1ccc(OC)cc1)C(=O)NCCC(c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 4/20 0.47
CCR5 P51681 3/20 0.45
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
LMNA P02545 3/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 2/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
RECQL P46063 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4394376 0.86 CCR5 (0.51) CASRCCR5LMNAALDH1A1MAPT
SCHEMBL4401960 0.82 ALDH1A1 (0.47) ALDH1A1POLBGAAMEN1KMT2A
SCHEMBL4394593 0.81 CASR (0.53) CASRALDH1A1GAA
Hydrochloric Acid SCHEMBL4391804 0.80 CASR (0.53) CASRALDH1A1GAA
SCHEMBL4394677 0.79 CASR (0.45) CASRLMNAALDH1A1MAPTGAA
SCHEMBL4399312 0.79 CASR (0.42) CASRCCR5CNR1LMNAGAA
Hydrochloric Acid SCHEMBL4403194 0.78 CASR (0.50) CASRALDH1A1GAAMEN1KMT2A
SCHEMBL4397200 0.77 SIGMAR1 (0.39) CNR1LMNAALDH1A1POLBGAA
SCHEMBL4395802 0.77 CASR (0.42) CASRCCR5NPC1
Hydrochloric Acid SCHEMBL4397072 0.76 CASR (0.41) CASRCCR5LMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1358171-A2 NOVEL UREA DERIVATIVES, METHOD FOR PREPARING SAME, USE THEREOF AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE Aventis Pharma S.A. (FR) 2003-11-05 EP disclosed
WO-2002059102-A2 UREA DERIVATIVES, METHOD FOR PREPARING SAME, USE THEREOF AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND USE AVENTIS PHARMA S.A. (FR) 2002-08-01 WO disclosed